QIAGEN receives several conditional, non-binding indications of interest, and decides to enter into discussions to explore potential strategic alterna-tives
VENLO, THE NETHERLANDS / ACCESSWIRE / November 15, 2019 / QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard: QIA) ("QIAGEN" or the "Company") announces it has begun a review of potential strategic alternatives after receiving several conditional, non-binding indications of interest for the acquisition of all issued and outstanding shares of the Company. The Supervisory Board and the Management Board of QIAGEN, in accordance with their...
Read more








